TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: leg press strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vertical row strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage increase in bone density at lumbar spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage increase in bone density at femoral neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of patients achieving adequate glycaemic control without hypoglycaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients experiencing hypoglycaemia
Endpoint domain: Adverse events/effects
Primary endpoint: Opioid requirements within the first 24 postoperative hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of recurrent esophageal variceal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cumulative incidence of celiac disease
Endpoint domain: Mortality/survival
Primary endpoint: post-treatment pain
Endpoint domain: Adverse events/effects
Primary endpoint: functional complications
Endpoint domain: Adverse events/effects
Primary endpoint: faster healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cued recall performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean reduction in YBOCS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients responding to treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: localization accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with HIV‐1 RNA < 50 copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Physical Performance Test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Status Questionnaire score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shoulder joint range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: total proteinuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Tolerance of treatment regimen
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Oral Health-Related Quality of Life (OHRQL)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Benefit recipiency at 6 months follow-up
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Inducibility of Atrial Fibrillation (AF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Atrial myocyte size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: digit range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1st CMC joint motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality of primary care
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: relative intestinal disaccharidase activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Aldrete score of 10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impulsive food choices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient satisfaction with care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: readmissions
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of non-pseudomonal gram-negative peritonitis
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of peritonitis-associated hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Severity of peritonitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary Albumin-to-Creatinine Ratio (UACR) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Ulcer-related healthcare costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Ulcer-related health resource utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Amplitude of P3a component
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Amplitude of P3b component
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: N1 latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Tolerability of nasal high flow therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: neonatal hypoglycemia
Endpoint domain: Adverse events/effects
Primary endpoint: maternal weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction of infarct size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement of subclinical left ventricular function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: FVC%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: DLCO-Hb
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: MRSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of successful tourniquet application
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Macular edema (centerpoint thickness ≥ 240 μm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wrinkle depth reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fitzpatrick score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of post-bronchiolitis wheezing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Sensitivity of EUS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of EUS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of EUS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WHO grades 2-3 alopecia
Endpoint domain: Adverse events/effects
Primary endpoint: DAS28‐ESR remission rate at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breast-cell proliferation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cumulated incidence of prostate cancer
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative postoperative fatigue scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Improvement in Canadian Cardiovascular Society (CCS) angina class
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients abstinent from nonmedical opioid use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: %BMIp95 reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Instructor perception of feedback technique
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Sedation assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delirium assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sudden death
Endpoint domain: Mortality/survival
Primary endpoint: Frequency of nonsustained ventricular tachycardia (NSVT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in maximum occlusal force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain at chewing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sUA control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Target plasma concentrations of allopurinol in cord blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events in neonates
Endpoint domain: Adverse events/effects
Primary endpoint: Grade 3/4 hematological toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of repeat episodes of deliberate self harm
Endpoint domain: Adverse events/effects
Primary endpoint: Time to successful puncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Citrate synthase activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tuberculosis-specific mortality
Endpoint domain: Mortality/survival
Primary endpoint: cecal intubation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart Rate (HR) variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood Pressure (BP) variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in systemic toxicity (neutropenia)
Endpoint domain: Adverse events/effects
Primary endpoint: disclosures of emotional and physical abuse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: chart documentation of IPV cases
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of bacteremia
Endpoint domain: Adverse events/effects
Primary endpoint: Cleavage rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of morphologically superior embryos
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to ETI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in student confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: decision to enter MAT for opioid addiction
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Surgical reentry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reflux symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ALP isoenzyme activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain at the hemostasis site
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of moderate to severe OHSS
Endpoint domain: Adverse events/effects
Primary endpoint: Mean number of grade III embryos
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall distress
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Postpartum infections
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of sleep-related breathing disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conversion from AF to sinus rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total strokes
Endpoint domain: Mortality/survival
Primary endpoint: Nonhemorrhagic strokes
Endpoint domain: Mortality/survival
Primary endpoint: overall behavioral skill scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cooling time to rectal temperature 38.25°C
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Awakenings during sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of debridement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma HIV-1 RNA reductions of >1 log(10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: thigh circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lysholm test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CD4 T-cell counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: HIV-1 specific cellular immune responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Negative behaviors during separation from parents
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical parameters (CAL, PD, BOP, GI, PI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IL‐1 β, IL‐6, and IL‐35 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Questionnaire response rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Response time to questionnaires
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: VAS scores on passive mobilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ejaculatory control
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ejaculatory confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: polymorphonuclear leukocyte phagocytosis activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Muscle sympathetic nerve activity (MSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: present pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: StO2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completed suicides
Endpoint domain: Mortality/survival
Primary endpoint: motivation to quit smoking
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: cumulative incidence of venous thromboembolism or death
Endpoint domain: Mortality/survival
Primary endpoint: Duration of exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ADAM score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QALY (Quality-Adjusted Life Year)
Endpoint domain: Resource use
Primary endpoint: mortality benefit
Endpoint domain: Mortality/survival
Primary endpoint: 8‐OHdG concentration in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrent thromboembolic events or death related to pulmonary embolism
Endpoint domain: Mortality/survival
Primary endpoint: Major bleeding episodes during nadroparin treatment
Endpoint domain: Adverse events/effects
Primary endpoint: mean changes in volume and thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean decrease in pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surface and color parameter performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of fractures at the implant connection level
Endpoint domain: Adverse events/effects
Primary endpoint: Wear evaluation at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knee muscle isokinetic strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Hb levels increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: HCV knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SF-36 energy/vitality
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quality of Well-Being Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Urinary enrichment ratio of betaine to choline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urinary enrichment of sarcosine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma enrichment ratio of d9-betain to d9-PtdCho
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sensitivity of speculoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of speculoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Missed cases of high grade squamous intra‐epithelial lesion or cancer
Endpoint domain: Adverse events/effects
Primary endpoint: Cmax of sotalol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of sotalol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative urinary excretion of sotalol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early graft function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: 3 years graft survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Total number of oral bacteria adhering to suture material
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of oral pathogens adhering to suture material
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: tumor-free survival rates
Endpoint domain: Mortality/survival
Primary endpoint: No vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Emetic episodes
Endpoint domain: Adverse events/effects
Primary endpoint: saturated fat intake in children
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: overall fat intake in children
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Social and emotional functioning scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ReHo value changes in brain areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: modified Rankin scale (mRS) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EuroQol Group‐5D (EQ‐5D) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Major grade III and IV adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: National Institute of Mental Health‐Trichotillomania Severity Scale Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Massachusetts General Hospital‐Hair Pulling Scale Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impressions‐Improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total electronic media use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DQOLY responses
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of CHD
Endpoint domain: Mortality/survival
Primary endpoint: Mean morning home PEFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Summary symptom and night-time asthma scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: TBUT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Discharge status after treatment
Endpoint domain: Mortality/survival
Primary endpoint: PT levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Improvement in esophageal obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: KFS improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median rigidity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in the appearance of scars
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction from treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Medication usage
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Six minutes walking distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective rating of pain (VAS scale)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: adherence to enhanced recovery pathway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced fear of falling
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in fall rates
Endpoint domain: Adverse events/effects
Primary endpoint: caecal intubation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patients' tolerance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: endoscopist's satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status